| 000 | 01507 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515034841.0 | ||
| 264 | 0 | _c20061103 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/dkl328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurkhardt, Olaf | |
| 245 | 0 | 0 |
_aOnce-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cOct 2006 |
||
| 300 |
_a822-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLehmann, Christine | |
| 700 | 1 | _aMadabushi, Rajanikanth | |
| 700 | 1 | _aKumar, Vipul | |
| 700 | 1 | _aDerendorf, Hartmut | |
| 700 | 1 | _aWelte, Tobias | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 58 _gno. 4 _gp. 822-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkl328 _zAvailable from publisher's website |
| 999 |
_c16473692 _d16473692 |
||